High-energy pulsed magnetic waves that reach up to 18 cm deep to treat osteoarthritis, chronic tendinopathies and joint pain — non-invasive, non-contact, no clothing removal. Delivered at our clinic in Singapore.
Extracorporeal Magnetotransduction Therapy (EMTT) uses very short, high-energy magnetic pulses to stimulate cell metabolism deep inside a joint or tendon. Unlike conventional PEMF (pulsed electromagnetic field) devices — which deliver low-energy waves suitable for surface tissue — EMTT delivers pulses in the kilotesla-per-second range, enough to reach up to 18 cm through skin, muscle and bone to the target structure.
Because the applicator is a magnetic-field coil rather than a physical probe, the therapy is non-contact and typically well-tolerated. You stay fully clothed. Metallic objects (belts, phone, keys) need to be moved from the treatment area, and patients with implanted electronic devices (pacemakers, insulin pumps) are not suitable candidates — we screen for that at the assessment.
EMTT is commonly paired with ESWT (shockwave therapy) — they work through complementary mechanisms, and the combined effect is often greater than either alone. The MagnetoLITH device (Storz Medical) is the most widely-cited clinical platform.
Chronic knee OA where cartilage loss and subchondral bone changes are driving persistent pain. EMTT stimulates cartilage-metabolism pathways and reduces inflammatory mediators — a non-invasive alternative for patients who don't want (or aren't ready for) injections.
Hip OA is difficult to reach with most surface therapies because the joint is deep. EMTT's 18 cm depth makes it one of the few non-invasive options that actually penetrates to the joint.
Rotator cuff tendinopathy, calcific tendinopathy, subacromial pain and shoulder OA — EMTT reaches all four structures without needing patient positioning changes.
Deep paraspinal muscles, facet joints and disc-adjacent structures are exactly where EMTT's depth advantage matters most. Useful adjunct alongside a movement rehabilitation programme.
Achilles tendinopathy, patellar tendinopathy, gluteal tendinopathy, tennis and golfer's elbow — especially the deep, hard-to-reach cases where surface treatments plateau.
The mechanotransduction effect on osteoblast activity makes EMTT a well-tolerated adjunct for stress fractures and slow-to-heal bone injuries, alongside proper offloading.
EMTT works best as a short course of 6–10 sessions across 3–5 weeks, often paired with ESWT and a loading programme. We book the whole schedule up-front so you can plan around it.
No referral required — walk in during opening hours or book online.
EMTT is a genuinely useful modality when the target tissue is deep — hip OA, chronic low back pain, deep tendinopathies — where surface therapies underperform. Its evidence base is more recent than for shockwave or HA injection, but the mechanotransduction pathway is well-characterised and the clinical results in our hands mirror the published series. We often pair EMTT with ESWT: they work through complementary pathways, and the combined effect is greater than either alone.
Like every modality, it isn't magic. It doesn't replace a proper diagnosis, and it doesn't replace the loading programme. We use it as one component of a coordinated plan — and we're happy to say when a different approach (injection, physiotherapy, surgical opinion) would give you a better result.
Message us on WhatsApp, use the enquiry form, or walk in during opening hours.